What is the incidence of human papillomavirus infection in inverted papillomas?

HPV Incidence in Inverted Papillomas

The incidence of HPV infection in sinonasal inverted papillomas ranges from approximately 12% to 62%, with significant variability across studies depending on detection methods and geographic populations.

Evidence Summary

The prevalence of HPV in inverted papillomas shows considerable heterogeneity in the literature, reflecting differences in detection methodology and patient populations:

Detection Rates by Study Quality

Most recent high-quality evidence demonstrates:

• 61.8% HPV positivity using PCR-based multiplex genotyping on microdissected tissue samples 1
• High-risk HPV types (particularly HPV-16) were found in 55.9% of HPV-positive cases, with HPV-16 accounting for 84.2% of high-risk infections 1
• Low-risk HPV types were present in 44.1% of HPV-positive cases, with HPV-54 predominating 1

Contrasting evidence from other rigorous studies shows:

• Only 2.7% HPV positivity in early, non-dysplastic inverted papillomas using in situ hybridization 2
• 12% HPV positivity in a larger series of 90 patients using PCR methodology 3
• HPV-11 was the most common type detected (9 of 11 positive cases) in this cohort 3

Key Clinical Correlations

Geographic and anatomic factors matter:

• Inverted papillomas originating from the maxillary sinus show significantly higher association with high-risk HPV (p = 0.019) 1
• Detection rates vary substantially by geographic region, suggesting population-specific differences 4

Malignant transformation context:

• HPV prevalence increases progressively with histologic severity: 14% in controls → 42% in IP without dysplasia → 70% in carcinoma in situ → 73% in invasive carcinoma 5
• High-risk HPV infection increases malignant transformation risk significantly (OR = 10.20,95% CI: 3.66-28.42) 4
• HPV-18 E6 oncogene shows the strongest correlation with progression (0% in controls vs 77% in invasive carcinoma) 5

Recurrence implications:

• HPV-positive inverted papillomas demonstrate higher recurrence rates: 66% in HPV-positive vs 6% in HPV-negative cases 6
• Meta-analysis confirms HPV infection associates with increased recurrence risk (OR = 2.05,95% CI: 1.31-3.19) 7

Clinical Interpretation

The wide range in reported HPV prevalence (2.7% to 62%) reflects:

1. Methodological differences: PCR-based techniques detect higher rates than in situ hybridization
2. Sample selection: Microdissected tumor tissue yields higher detection than whole tissue samples
3. Population variation: Geographic and demographic factors influence prevalence
4. Tumor characteristics: Dysplastic and malignant lesions harbor HPV more frequently than benign lesions

Important Caveats

• HPV detection does not definitively establish causation in inverted papilloma pathogenesis 2
• The relatively low HPV rates in early, non-dysplastic lesions (compared to 85-95% in established HPV-related neoplasias like cervical or oropharyngeal cancer) suggest HPV may be a secondary infection rather than primary etiologic agent 2
• When HPV is present, particularly high-risk types, it appears to contribute to tumor biology through EGFR upregulation and increased malignant potential 3

The most conservative estimate from high-quality evidence suggests approximately 12-16% of inverted papillomas harbor HPV 8, 3, though rates up to 40-62% have been reported using more sensitive detection methods 8, 1.